Evaluation of the Safety and Efficacy of Systemic Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Locally Inoperable Progressive Soft Tissue Metastases
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Jens Atzpodien, MD, PhD
Principal Investigator
Fachklinik Hornheide an der Universität Münster
Germany: Regulatory Authorities, Northrhine-Westfalia
HOT-100
NCT00264056
December 2005
June 2007
Name | Location |
---|